nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ABVD in the treatment of Hodgkin's disease
|
Bonfante, Valeria |
|
1992 |
19 |
2S5 |
p. 38-45 8 p. |
artikel |
2 |
Bleomycin and tetracycline in malignant pleural effusions: A review
|
Moffett, Michael J. |
|
1992 |
19 |
2S5 |
p. 59-63 5 p. |
artikel |
3 |
Bleomycin in non-Hodgkin's lymphoma
|
Bayer, Robert A. |
|
1992 |
19 |
2S5 |
p. 46-53 8 p. |
artikel |
4 |
Bleomycin pharmacology: Mechanism of action and resistance, and clinical pharmacokinetics
|
Dorr, Robert T. |
|
1992 |
19 |
2S5 |
p. 3-8 6 p. |
artikel |
5 |
Bleomycin pulmonary toxicity: Current status and future directions
|
Comis, Robert L. |
|
1992 |
19 |
2S5 |
p. 64-70 7 p. |
artikel |
6 |
Chemotherapy of male and female germ cell tumors
|
Williams, Stephen D. |
|
1992 |
19 |
2S5 |
p. 19-24 6 p. |
artikel |
7 |
Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer
|
Buxton, E.J. |
|
1992 |
19 |
2S5 |
p. 9-18 10 p. |
artikel |
8 |
Introduction
|
Krakoff, Irwin H. |
|
1992 |
19 |
2S5 |
p. 1-2 2 p. |
artikel |
9 |
The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary site
|
Hainsworth, John D. |
|
1992 |
19 |
2S5 |
p. 54-58 5 p. |
artikel |
10 |
Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens
|
Ireland-Gill, Anne |
|
1992 |
19 |
2S5 |
p. 32-37 6 p. |
artikel |
11 |
Treatment of recurrent and metastatic head and neck cancer with cisplatin/etoposide/bleomycin
|
Osoba, David |
|
1992 |
19 |
2S5 |
p. 25-31 7 p. |
artikel |